Skip to main content
Clinical Trials/ACTRN12622000011785
ACTRN12622000011785
Recruiting
N/A

Evaluating venous compliance in heart failure

The Alfred Hospital0 sites70 target enrollmentJanuary 11, 2022

Overview

Phase
N/A
Intervention
Not specified
Conditions
Not specified
Sponsor
The Alfred Hospital
Enrollment
70
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
January 11, 2022
End Date
TBD
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
The Alfred Hospital

Eligibility Criteria

Inclusion Criteria

  • Investigative group:
  • \- diagnosed Heart failure, aiming for an equal share of 25 HFpEF patients and 25 HFrEF patients
  • \- NYHA II\-IV.
  • \- Ischaemic or non\-Ischaemic aetiology.
  • \- Stable heart failure therapy for 1 month (a \<50% adjustment to diuretics is permissible)
  • Healthy volunteers:
  • \-never diagnosed with heart failure (nil diagnosis of cardiomyopathy)

Exclusion Criteria

  • oPrior heart transplantation
  • oComplex congenital heart disease
  • oUnstable heart failure requiring high dose inotropes (milrinone \>15ug/min, dobutamine \>5 ug/kg/min or adrenaline \> 2ug/min) or mechanical circulatory support

Outcomes

Primary Outcomes

Not specified

Similar Trials